Numerous safety issues are dealt with by the NTLF staff over the course of a year. 1. HTO emissions reductions have been achieved over the past five years by a number of changes in Facility design, including the incorporation of tritium recycling and use of oil-less vacuum pumps. We have continued to closely monitor weekly releases and correlate them with experimental activities and any hardware problems. The contribution of various tritiation system components (e.g. the copper oxide tubes) to routine releases is still being investigated and evaluated. 2. One procedure not previously addressed from the point of view of waste control is sample processing after a tritiation reaction. Previously, during sample workup, the low volume, high activity solvent used for tritiation was co-mingled with larger volumes of much lower activity. We have separated these functions by inserting a liquid nitrogen cooled solvent trap filled with silica gel and placed between the tritiation reaction vessel and the lyophilization trap. Thus, the high level tritiated solvent is rapidly adsorbed and sealed in this intermediate trap. Larger solvent volumes can then be trapped into the lyophilizer. Following this procedure, tritium release to the work boxes has become barely detectable during the draining of the lyophilizer. 3. Contamination control and personnel exposure have become very important priorities at LBNL. In addition to the routine floor swipes within the Facility, a program of sampling other sites in and around the NTLF has been undertaken. DOE reviews of personal dosimetry and contamination control procedures and performance are conducted at least annually. 4. Safety documents are under constant review. The actual form and overlap of various DOE and regulatory agency rules and orders is continually evolving and requires frequent changes in existing documents, as well as creation and documentation of new procedures. The formalization and documentation of training procedures for Users of tritium is a high priority at LBNL. 5. A Technical and Safety Advisory Committee was proposed for the NTLF in the most recent competitive renewal. As distinct from the Scientific Advisory Committee, this group focuses on keeping the NTLF staff current on all the safety issues, procedures and equipment they should understand and have for smooth operation of the Facility. We had the initial meeting of this group in April 1995, and met again in January 1996. 6. A member of the NTLF staff is a representative on the Structural Biology Division Safety Committee, and attends monthly meetings. This representative ensures the effective communication of safety requirements and information between the Divisional management and NTLF staff. This role has become very important with the much higher priority of chemical safety, and the need for increased awareness of waste disposal procedures and requirements. 7. A member of the NTLF staff is also a representative on the LBNL ALARA Working Committee, and attends monthly meetings. This group has been newly created to address all aspects of radiation exposure at LBNL, and to make recommendations to management regarding ALARA practices and procedures. 8. A Chemical Inventory is maintained at LBNL, and is submitted to local Regulatory agencies on a yearly basis. The NTLF needs to maintain and report its own Chemical Inventory, for incorporation into the larger LBNL database. 9. During 1995 the NTLF was chosen as a pilot for the DOE """"""""Necessary and Sufficient Standards"""""""" process. This involved the selection of only those standards deemed to add EH&S value to a given operation, and has allowed movement away from excessive and burdensome regulation. In the short term, this process required considerable work in implementation, with the promise of long-term gain in reduced EH&S oversight. After completion of the pilot in late September 1995, the NTLF was designated a DOE Radiological Facility, thus avoiding compliance with the DOE Nuclear Facility orders. With extensive experience in this process, Williams will be involved in advising other N&S processes throughout the DOE complex over the next year.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
5P41RR001237-14
Application #
5222984
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1996
Total Cost
Indirect Cost
Singh, Navneet; Moody, Alan R; Zhang, Bowen et al. (2017) Age-Specific Sex Differences in Magnetic Resonance Imaging-Depicted Carotid Intraplaque Hemorrhage. Stroke 48:2129-2135
Paul-Pletzer, Kalanethee; Yamamoto, Takeshi; Ikemoto, Noriaki et al. (2005) Probing a putative dantrolene-binding site on the cardiac ryanodine receptor. Biochem J 387:905-9
Wang, Huimin; Shimizu, Eiji; Tang, Ya-Ping et al. (2003) Inducible protein knockout reveals temporal requirement of CaMKII reactivation for memory consolidation in the brain. Proc Natl Acad Sci U S A 100:4287-92
Paul-Pletzer, Kalanethee; Yamamoto, Takeshi; Bhat, Manjunatha B et al. (2002) Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor. J Biol Chem 277:34918-23
Westler, William M; Frey, Perry A; Lin, Jing et al. (2002) Evidence for a strong hydrogen bond in the catalytic dyad of transition-state analogue inhibitor complexes of chymotrypsin from proton-triton NMR isotope shifts. J Am Chem Soc 124:4196-7
Tomizawa, M; Wen, Z; Chin, H L et al. (2001) Photoaffinity labeling of insect nicotinic acetylcholine receptors with a novel [(3)H]azidoneonicotinoid. J Neurochem 78:1359-66
Than, C; Morimoto, H; Williams, P G et al. (2001) Preparation, NMR characterization, and labeling reactions of tritiated triacetoxy sodium borohydride. J Org Chem 66:3602-5
Saljoughian, M; Williams, P G (2000) Recent developments in tritium incorporation for radiotracer studies. Curr Pharm Des 6:1029-56
Cianci, C; Yu, K L; Dischino, D D et al. (1999) pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion. J Virol 73:1785-94
Palnitkar, S S; Bin, B; Jimenez, L S et al. (1999) [3H]Azidodantrolene: synthesis and use in identification of a putative skeletal muscle dantrolene binding site in sarcoplasmic reticulum. J Med Chem 42:1872-80

Showing the most recent 10 out of 28 publications